Skip to main content
UniHealth

Doctor search

David J Wong, MD

Dermatology · Stanford

NPI 1316972201

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
15
5 carriers
Offices
5

Offices

5 locations · Stanford Health Care · Direct Dermatology Professionals PC

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

15 plans · 5 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wong’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

15 of 15 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A84286 · Current

Licensed to practise in California · since 2003 · expires 2026-12-31 · University of Washington School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$170,330

Medicare paid this office $170,330 for 648 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)276$39,192$89
Short return visit (20+ min)316$24,807$62
Destruction of skin growth, 1-14 growths114$13,150$89
Biopsy of related skin growth, first growth121$8,213$67
Destruction of precancer skin growth, 1 growth132$7,137$42
See all 13 services
Every Original Medicare service billed
Return visit (30+ min)276$39,192$89
Short return visit (20+ min)316$24,807$62
Destruction of skin growth, 1-14 growths114$13,150$89
Biopsy of related skin growth, first growth121$8,213$67
Destruction of precancer skin growth, 1 growth132$7,137$42
New patient visit (30+ min)85$5,941$70
New patient visit (45+ min)43$4,649$108
Destruction of precancer skin growth, 15 or more growths23$3,916$126
Punch biopsy, first skin growth29$3,044$101
Destruction of precancer skin growth, 2-14 growths90$2,345$5
Biopsy of related skin growth, each additional growth25$1,245$42
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes13$347$20
Injection, triamcinolone acetonide, not otherwise specified, 10 mg12$24None

Procedures Medicare counted

Procedure volume Medicare published
Removal of nail tissue1-10None
Removal of skin lesions681More than 90% of doctors who do this
Removal or shaving of skin growth15More than 68% of doctors who do this
Skin biopsy275More than 89% of doctors who do this

Who their Medicare patients are

648 Original Medicare patients in 2024. Average age 68 · Under 65 22% · 85 and older 8% · Women 55% · Also on Medicaid 78% · Health risk score 1.29. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.

Conditions among them: High blood pressure 71% · Diabetes 38% · Chronic kidney disease 23% · Depression 23% · Coronary heart disease 20% · COPD 15% · Heart failure 13% · Atrial fibrillation 12% · Cancer 10% · Stroke 8% · Dementia 6%.

The office billed $509,972, Medicare allowed $235,627 and paid $170,330; for 2,457 services of 28 kinds; $24 of it was for drugs given in the office and $170,306 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20246482,457681.29$509,972$170,330
20235221,896681.20$331,604$100,548
20226321,885671.26$307,736$87,090
20218732,748671.24$448,278$128,676
20206021,772671.35$300,829$74,166
20193461,202671.37$190,363$53,078
20182371,040661.33$145,946$38,030
2017168780661.19$93,519$24,371
2016107514671.17$58,201$15,370
2015134508711.29$55,807$15,944
201437201741.16$25,148$4,933
201350180741.63$18,319$5,268

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 15 services

Original Medicare services billed in 2023
Short return visit (20+ min)323$28,066$61
Return visit (30+ min)177$22,759$88
Destruction of skin growth, 1-14 growths103$12,078$86
Biopsy of related skin growth, first growth100$7,228$66
Destruction of precancer skin growth, 1 growth115$5,986$41
Destruction of precancer skin growth, 15 or more growths21$3,174$122
Punch biopsy, first skin growth29$2,960$99
Destruction of skin growth, 15 or more growths16$2,394$96
Destruction of precancer skin growth, 2-14 growths81$2,134$4
New patient visit (45+ min)15$1,734$116
New patient visit (30+ min)19$1,322$70
Biopsy of related skin growth, each additional growth24$1,192$40
Injection into skin growth, 1-7 growths11$805$40
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes26$676$22
Injection, triamcinolone acetonide, not otherwise specified, 10 mg13$26None

2022: 12 services

Original Medicare services billed in 2022
Short return visit (20+ min)405$31,156$55
Return visit (30+ min)102$11,873$89
Destruction of skin growth, 1-14 growths65$7,123$78
Biopsy of related skin growth, first growth95$6,629$65
Destruction of precancer skin growth, 1 growth94$4,964$41
New patient visit (45+ min)51$4,692$92
Destruction of precancer skin growth, 15 or more growths23$4,182$131
New patient visit (30+ min)61$3,470$57
New patient visit (15+ min)94$3,251$35
Punch biopsy, first skin growth27$2,626$94
Destruction of precancer skin growth, 2-14 growths74$2,140$4
Biopsy of related skin growth, each additional growth22$1,051$35

2021: 15 services

Original Medicare services billed in 2021
Short return visit (20+ min)535$46,370$59
New patient visit (30+ min)194$12,582$65
Return visit (30+ min)110$12,509$89
Destruction of skin growth, 1-14 growths110$11,854$86
Biopsy of related skin growth, first growth128$10,242$71
Destruction of precancer skin growth, 1 growth131$6,477$37
Destruction of precancer skin growth, 15 or more growths36$5,944$119
New patient visit (15+ min)145$5,348$37
Punch biopsy, first skin growth39$4,374$102
Destruction of precancer skin growth, 2-14 growths97$3,750$5
New patient visit (45+ min)25$2,525$101
Biopsy of related skin growth, each additional growth30$1,931$43
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes22$759$29
Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes19$294$12
Injection, triamcinolone acetonide, not otherwise specified, 10 mg18$26None

2020: 14 services

Original Medicare services billed in 2020
Short return visit (20+ min)393$28,274$47
Destruction of skin growth, 1-14 growths88$9,636$76
Biopsy of related skin growth, first growth111$7,448$64
New patient visit (15+ min)131$5,477$42
Destruction of precancer skin growth, 1 growth100$4,463$37
Destruction of precancer skin growth, 15 or more growths27$4,106$111
New patient visit (30+ min)68$3,615$53
Return visit (30+ min)34$3,487$71
Destruction of precancer skin growth, 2-14 growths67$1,720$4
Punch biopsy, first skin growth14$1,243$83
Biopsy of related skin growth, each additional growth24$1,002$42
Injection into skin growth, 1-7 growths13$794$36
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes14$358$24
Injection, triamcinolone acetonide, not otherwise specified, 10 mg13$20None

2019: 10 services

Original Medicare services billed in 2019
Short return visit (20+ min)303$23,161$52
Destruction of skin growth, 1-14 growths69$8,118$84
Biopsy of related skin growth, first growth100$7,128$69
Destruction of precancer skin growth, 15 or more growths18$2,875$115
Destruction of precancer skin growth, 1 growth62$2,799$38
Punch biopsy, first skin growth23$2,257$98
Return visit (30+ min)17$1,784$78
Destruction of precancer skin growth, 2-14 growths49$1,317$4
Biopsy of related skin growth, each additional growth26$1,182$41
Injection, triamcinolone acetonide, not otherwise specified, 10 mg12$16None

2018: 8 services

Original Medicare services billed in 2018
Short return visit (20+ min)222$16,587$49
Destruction of skin growth, 1-14 growths46$5,328$77
Biopsy of single growth of skin and/or tissue63$5,275$72
Destruction of precancer skin growth, 1 growth55$2,933$39
Destruction of precancer skin growth, 15 or more growths19$2,639$98
Return visit (30+ min)17$1,367$72
Destruction of precancer skin growth, 2-14 growths44$1,337$4
Biopsy of each additional growth of skin and/or tissue15$546$25

2017: 6 services

Original Medicare services billed in 2017
Short return visit (20+ min)163$11,657$48
Biopsy of single growth of skin and/or tissue52$4,054$69
Destruction of skin growth, 1-14 growths37$3,269$80
Destruction of precancer skin growth, 1 growth39$1,913$35
Destruction of precancer skin growth, 2-14 growths31$1,253$4
Biopsy of each additional growth of skin and/or tissue17$614$25

2016: 6 services

Original Medicare services billed in 2016
Short return visit (20+ min)97$6,434$46
Destruction of skin growth, 1-14 growths30$2,835$77
Biopsy of single growth of skin and/or tissue28$1,664$57
Destruction of precancer skin growth, 1 growth30$1,645$40
Destruction of precancer skin growth, 2-14 growths23$803$4
Biopsy of each additional growth of skin and/or tissue13$406$25

2015: 9 services

Original Medicare services billed in 2015
Short return visit (20+ min)38$3,162$55
Short return visit (20+ min)47$3,017$42
New patient visit (30+ min)14$1,103$79
Biopsy of single growth of skin and/or tissue13$1,072$82
Destruction of precancer skin growth, 1 growth19$907$41
New patient visit (15+ min)14$821$59
Destruction of precancer skin growth, 1 growth11$735$49
Destruction of precancer skin growth, 2-14 growths11$456$5
Destruction of precancer skin growth, 2-14 growths18$232$2

2014: 3 services

Original Medicare services billed in 2014
Short return visit (20+ min)31$2,091$43
Destruction of precancer skin growth, 1 growth18$1,003$42
Destruction of precancer skin growth, 2-14 growths14$177$2

2013: 1 service

Original Medicare services billed in 2013
Short return visit (20+ min)41$2,646$38

Medicaid work

$1,030,288 in 2024

Medicaid paid $1,030,288 for 16,282 billed services this clinician did in 2024, up to 621 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Return visit (30+ min)4,426$245,130
Excimer laser treatment for psoriasis; over 500 sq cm845$179,939
Short return visit (20+ min)3,650$134,107
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions1,425$114,543
OFF/OP CNSLTJ NEW/EST MOD 401,023$75,132
Excimer laser treatment for psoriasis; total area less than 250 sq cm1,049$67,500
Excimer laser treatment for psoriasis; 250 sq cm to 500 sq cm463$50,041
Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion545$43,176
Punch biopsy of skin (including simple closure, when performed); single lesion249$22,442
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES652$19,467
New patient visit (45+ min)170$16,340
New patient visit (30+ min)265$15,891
Medicaid work by year
202416,28222621$1,030,288
202315,73218475$569,019
202214,33518591$494,420
202120,50620706$833,835
202015,05818687$589,671
201916,46217798$650,299
201813,15016671$672,572
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Return visit (30+ min)3,745$143,296
Short return visit (20+ min)4,325$122,898
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions1,826$95,415
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes620$51,085
Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion674$32,228
OFF/OP CNSLTJ NEW/EST MOD 40622$25,146
Punch biopsy of skin (including simple closure, when performed); single lesion264$18,151
Excimer laser treatment for psoriasis; total area less than 250 sq cm150$16,786
Injection, intralesional; up to and including 7 lesions556$12,721
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions230$10,500
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion369$9,838
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES568$9,182

2022

Largest Medicaid services in 2022
Short return visit (20+ min)5,124$124,501
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions1,496$93,089
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes1,083$84,851
Return visit (30+ min)1,938$70,001
Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion593$27,784
OFF/OP CNSLTJ NEW/EST MOD 40379$14,640
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES725$13,300
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions218$11,695
Punch biopsy of skin (including simple closure, when performed); single lesion240$10,800
Injection, intralesional; up to and including 7 lesions368$8,897
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion310$8,174
OFF/OP CONSLTJ NEW/EST SF 20515$8,169

2021

Largest Medicaid services in 2021
Short return visit (20+ min)7,034$188,179
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions2,203$165,463
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes2,130$164,000
Return visit (30+ min)1,868$84,534
OFF/OP CONSLTJ NEW/EST SF 201,415$62,485
Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion721$39,312
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES1,220$29,989
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions242$22,320
Punch biopsy of skin (including simple closure, when performed); single lesion306$17,558
New patient visit (30+ min)248$12,477
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion440$11,384
Injection, intralesional; up to and including 7 lesions557$10,862

2020

Largest Medicaid services in 2020
Short return visit (20+ min)6,458$159,279
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions2,124$155,993
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes579$48,985
OFF/OP CONSLTJ NEW/EST SF 20944$48,877
Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion781$45,561
Return visit (30+ min)707$41,758
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions301$21,325
Punch biopsy of skin (including simple closure, when performed); single lesion196$15,418
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion369$11,215
New patient visit (30+ min)210$9,581
Injection, intralesional; up to and including 7 lesions517$9,320
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES584$5,781

2019

Largest Medicaid services in 2019
Short return visit (20+ min)7,536$194,536
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions2,410$188,531
Online evaluation and management service provided by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient or guardian, not originating from a related E/M service provided within the previous 7 days, using the Internet or similar electronic communications network886$66,817
Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion1,022$50,099
OFF/OP CONSLTJ NEW/EST SF 20549$29,244
Punch biopsy of skin (including simple closure, when performed); single lesion338$27,223
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions296$26,226
Return visit (30+ min)366$17,389
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion392$12,928
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES572$9,453
Injection, intralesional; up to and including 7 lesions572$9,027
Injection, intralesional; more than 7 lesions221$5,616

2018

Largest Medicaid services in 2018
Short return visit (20+ min)6,386$236,629
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions2,132$211,155
Online evaluation and management service provided by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient or guardian, not originating from a related E/M service provided within the previous 7 days, using the Internet or similar electronic communications network882$71,994
Service964$37,008
OFF/OP CONSLTJ NEW/EST SF 20389$22,408
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions182$19,930
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES397$17,164
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion264$16,054
Return visit (30+ min)263$14,842
Injection, intralesional; up to and including 7 lesions338$8,107
Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)179$4,807
Injection, intralesional; more than 7 lesions114$3,990

Drugs they prescribed that Part D paid

$1,904,840

Pharmacies billed $1,904,840 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,057) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.

796 generic and 261 brand-name prescriptions · $1,904,840 in drug cost · 24 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Humira(Cf)66$520,895$7,892
Skyrizi22$441,165$20,053
Dupixent74$277,774$3,754
Tremfya15$198,619$13,241
Taltz23$150,145$6,528
See all 21 drugs
Every Part D drug this clinician prescribed
Humira(Cf)66$520,895$7,892
Skyrizi22$441,165$20,053
Dupixent74$277,774$3,754
Tremfya15$198,619$13,241
Taltz23$150,145$6,528
Otezla22$102,263$4,648
Dupixent12$44,361$3,697
Clobetasol Propionate82$6,416$78
Betamethasone Diprop Augmented51$3,148$62
Calcipotriene12$2,189$182
Fluocinonide57$2,002$35
Halobetasol Propionate34$1,972$58
Ketoconazole97$1,579$16
Clindamycin Phosphate33$1,322$40
Triamcinolone Acetonide121$1,033$9
Metronidazole13$501$39
Hydroxyzine36$434$12
Hydrocortisone72$348$5
Mupirocin23$178$8
Clotrimazole18$163$9
Prednisone19$116$6

Year by year

Part D prescribing by year
20241,0572410% (0)25%$1,904,840
20238432150% (0)14%$899,423
20221,313329NoneNone$673,827
20216031540% (0)None$487,134
20204861260% (0)None$307,957
20192951000% (0)21%$135,313
2018182640% (0)16%$54,338
2017198640% (0)17%$156,890
201616155NoneNone$85,617
201520557NoneNone$52,334
201419251None15%$53,528
20132611150% (0)20%$56,726

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 17 drugs

Part D drugs prescribed in 2023
Skyrizi20$428,379$21,419
Dupixent36$139,306$3,870
Clobetasol Propionate92$15,122$164
Tacrolimus19$4,789$252
Acitretin11$3,772$343
Betamethasone Diprop Augmented44$3,532$80
Metronidazole27$3,080$114
Halobetasol Propionate22$2,901$132
Fluocinonide37$2,814$76
Fluorouracil15$1,906$127
Triamcinolone Acetonide104$1,580$15
Ketoconazole86$1,554$18
Clindamycin Phosphate40$1,429$36
Doxycycline Hyclate11$842$77
Hydroxyzine36$772$21
Hydrocortisone58$536$9
Mupirocin18$308$17

2022: 24 drugs

Part D drugs prescribed in 2022
Humira(Cf)20$137,404$6,870
Cosentyx Pen (2 Pens)12$102,370$8,531
Dupixent23$86,566$3,764
Clobetasol Propionate113$22,681$201
Betamethasone Diprop Augmented59$6,892$117
Tacrolimus18$5,046$280
Metronidazole34$4,217$124
Triamcinolone Acetonide265$3,905$15
Fluocinonide52$3,751$72
Betamethasone Dipropionate29$3,260$112
Clindamycin Phosphate51$2,587$51
Ketoconazole80$2,300$29
Doxycycline Monohydrate29$2,281$79
Halobetasol Propionate14$2,150$154
Fluocinolone Acetonide14$1,608$115
Hydroxyzine98$1,150$12
Hydrocortisone130$911$7
Mometasone Furoate17$761$45
Minocycline20$456$23
Mupirocin27$407$15
Methotrexate11$391$36
Acyclovir14$224$16
Prednisone13$175$13
Spironolactone11$123$11

2021: 13 drugs

Part D drugs prescribed in 2021
Humira(Cf)30$190,201$6,340
Tremfya13$163,881$12,606
Clobetasol Propionate47$3,808$81
Metronidazole26$2,828$109
Triamcinolone Acetonide94$1,679$18
Ketoconazole49$1,078$22
Hydroxyzine56$1,025$18
Fluocinonide19$968$51
Betamethasone Diprop Augmented19$635$33
Prednisone32$575$18
Doxycycline Monohydrate12$542$45
Hydrocortisone38$241$6
Hydroxyzine Pamoate14$57$4

2020: 12 drugs

Part D drugs prescribed in 2020
Humira(Cf)25$146,717$5,869
Fluocinonide32$1,799$56
Clobetasol Propionate28$1,764$63
Triamcinolone Acetonide80$988$12
Ketoconazole31$887$29
Doxycycline Hyclate13$782$60
Betamethasone Diprop Augmented18$689$38
Clindamycin Phosphate14$632$45
Hydroxyzine20$357$18
Gabapentin12$303$25
Prednisone19$220$12
Hydrocortisone24$176$7

2019: 8 drugs

Part D drugs prescribed in 2019
Dexilant13$4,726$364
Clindamycin Phosphate14$1,519$109
Fluocinonide16$1,135$71
Triamcinolone Acetonide30$702$23
Ketoconazole24$396$17
Hydroxyzine20$250$13
Prednisone16$196$12
Hydrocortisone12$79$7

2018: 1 drug

Part D drugs prescribed in 2018
Triamcinolone Acetonide30$373$12

2017: 3 drugs

Part D drugs prescribed in 2017
Humira11$55,017$5,002
Clobetasol Propionate28$10,137$362
Triamcinolone Acetonide47$758$16

2016: 3 drugs

Part D drugs prescribed in 2016
Clobetasol Propionate16$10,307$644
Fluocinonide13$1,387$107
Hydrocortisone12$83$7

2015: 5 drugs

Part D drugs prescribed in 2015
Clobetasol Propionate25$5,641$226
Fluocinonide16$1,194$75
Clindamycin Phosphate16$1,017$64
Hydrocortisone17$656$39
Triamcinolone Acetonide35$616$18

2014: 4 drugs

Part D drugs prescribed in 2014
Clobetasol Propionate33$2,083$63
Hydrocortisone21$862$41
Triamcinolone Acetonide22$555$25
Ketoconazole14$293$21

2013: 7 drugs

Part D drugs prescribed in 2013
Metronidazole11$1,633$148
Desonide22$1,210$55
Clobetasol Propionate38$1,200$32
Triamcinolone Acetonide27$841$31
Fluocinonide21$617$29
Hydroxyzine23$462$20
Pantoprazole17$330$19

Money from drug and device companies

$812 in 2025

Industry payments by year
20251639None$812
20241038None$738
2023639None$690
2022319None$384
2021222None$342
202014None$82
201924None$70

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AbbvieSkyrizi$115
5 payments
  • Meals for Skyrizi · 2025-11-19 · $19
  • Meals for Skyrizi · 2025-11-07 · $31
  • Meals for Skyrizi · 2025-09-11 · $19
  • Meals for Skyrizi · 2025-06-04 · $19
  • Meals for Skyrizi · 2025-01-14 · $26
STRATA Skin SciencesXtrac$87
9 payments
  • Meals for Xtrac · 2025-12-22 · $11
  • Meals for Xtrac · 2025-12-04 · $7
  • Meals for Xtrac · 2025-09-25 · $9
  • Meals for Xtrac · 2025-08-21 · $10
  • Meals for Xtrac · 2025-06-19 · $7
  • Meals for Xtrac · 2025-05-13 · $10
  • Meals for Xtrac · 2025-04-02 · $9
  • Meals for Xtrac · 2025-02-11 · $12
  • Meals for Xtrac · 2025-01-14 · $12
StrykerAugment Injectable$82
1 payment
  • Meals for Augment Injectable · 2025-10-29 · $82
IncyteOpzelura$62
4 payments
  • Meals for Opzelura · 2025-11-07 · $14
  • Meals for Opzelura · 2025-10-22 · $14
  • Meals for Opzelura · 2025-10-01 · $16
  • Meals for Opzelura · 2025-02-08 · $17
AmgenOtezla$61
3 payments
  • Meals for Otezla · 2025-11-04 · $23
  • Meals for Otezla · 2025-07-15 · $16
  • Meals for Otezla · 2025-02-18 · $22
OrganonVtama$59
2 payments
  • Meals for Vtama · 2025-10-21 · $25
  • Meals for Vtama · 2025-01-09 · $34
See all 39 published payments
Every published payment
STRATA Skin SciencesMeals · 2025-12-22Xtrac$11
Novartis PharmaceuticalsMeals · 2025-12-09Rhapsido$35
STRATA Skin SciencesMeals · 2025-12-04Xtrac$7
AbbvieMeals · 2025-11-19Skyrizi$19
AbbvieMeals · 2025-11-07Skyrizi$31
IncyteMeals · 2025-11-07Opzelura$14
AmgenMeals · 2025-11-04Otezla$23
Arcutis BiotherapeuticsMeals · 2025-11-04Zoryve$14
StrykerMeals · 2025-10-29Augment Injectable$82
IncyteMeals · 2025-10-22Opzelura$14
OrganonMeals · 2025-10-21Vtama$25
Galderma Laboratories L.P.Meals · 2025-10-08Nemluvio$17
IncyteMeals · 2025-10-01Opzelura$16
Arcutis BiotherapeuticsMeals · 2025-09-30Zoryve$14
STRATA Skin SciencesMeals · 2025-09-25Xtrac$9
AbbvieMeals · 2025-09-11Skyrizi$19
Novartis PharmaceuticalsMeals · 2025-08-26Xolair$17
STRATA Skin SciencesMeals · 2025-08-21Xtrac$10
E.R. Squibb & Sons L.L.C.Meals · 2025-08-19Sotyktu$21
AmgenMeals · 2025-07-15Otezla$16
Galderma Laboratories L.P.Meals · 2025-07-09Nemluvio$23
STRATA Skin SciencesMeals · 2025-06-19Xtrac$7
Verrica PharmaceuticalsMeals · 2025-06-17Ycanth$23
AbbvieMeals · 2025-06-04Skyrizi$19
Galderma Laboratories L.P.Meals · 2025-05-21Nemluvio$16
STRATA Skin SciencesMeals · 2025-05-13Xtrac$10
E.R. Squibb & Sons L.L.C.Meals · 2025-05-02Sotyktu$21
STRATA Skin SciencesMeals · 2025-04-02Xtrac$9
SpringWorks TherapeuticsMeals · 2025-03-14Gomekli$29
AlmirallMeals · 2025-03-05Klisyri$28
AmgenMeals · 2025-02-18Otezla$22
STRATA Skin SciencesMeals · 2025-02-11Xtrac$12
IncyteMeals · 2025-02-08Opzelura$17
UcbMeals · 2025-02-05Bimzelx$24
MIMEDX GroupMeals · 2025-01-28None$45
Lilly USAMeals · 2025-01-20Taltz$20
AbbvieMeals · 2025-01-14Skyrizi$26
STRATA Skin SciencesMeals · 2025-01-14Xtrac$12
OrganonMeals · 2025-01-09Vtama$34
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $738

Payments by company in 2024
UcbBimzelx$164
9 payments
  • Meals for Bimzelx · 2024-12-18 · $11
  • Meals for Bimzelx · 2024-12-17 · $12
  • Meals for Bimzelx · 2024-12-07 · $30
  • Meals for Bimzelx · 2024-09-24 · $12
  • Meals for Bimzelx · 2024-09-11 · $47
  • Meals for Bimzelx · 2024-07-23 · $11
  • Meals for Bimzelx · 2024-05-14 · $8
  • Meals for Bimzelx · 2024-02-27 · $9
  • Meals for Bimzelx · 2024-01-23 · $22
AmgenOtezla$152
8 payments
  • Meals for Otezla · 2024-12-10 · $28
  • Meals for Otezla · 2024-12-03 · $12
  • Meals for Otezla · 2024-11-19 · $7
  • Meals for Otezla · 2024-10-24 · $15
  • Meals for Otezla · 2024-10-01 · $23
  • Meals for Otezla · 2024-04-23 · $26
  • Meals for Otezla · 2024-02-13 · $32
  • Meals for Otezla · 2024-01-16 · $9
STRATA Skin SciencesXtrac$105
8 payments
  • Meals for Xtrac · 2024-12-18 · $7
  • Meals for Xtrac · 2024-12-10 · $10
  • Meals for Xtrac · 2024-11-05 · $12
  • Meals for Xtrac · 2024-09-26 · $11
  • Meals for Xtrac · 2024-09-17 · $12
  • Meals for Xtrac · 2024-06-04 · $10
  • Meals for Xtrac · 2024-04-29 · $23
  • Meals for Xtrac · 2024-01-15 · $17
IncyteOpzelura$90
4 payments
  • Meals for Opzelura · 2024-11-22 · $14
  • Meals for Opzelura · 2024-08-23 · $26
  • Meals for Opzelura · 2024-07-26 · $27
  • Meals for Opzelura · 2024-02-02 · $23
Novartis PharmaceuticalsCosentyx$66
2 payments
  • Meals for Cosentyx · 2024-02-27 · $32
  • Meals for Cosentyx · 2024-01-12 · $34
AbbvieSkyrizi$66
3 payments
  • Meals for Skyrizi · 2024-12-18 · $19
  • Meals for Skyrizi · 2024-10-16 · $15
  • Meals for Skyrizi · 2024-06-19 · $32
Dermavant SciencesVtama$29
1 payment
  • Meals for Vtama · 2024-07-12 · $29
Sun Pharmaceutical IndustriesIlumya$24
1 payment
  • Meals for Ilumya · 2024-02-23 · $24
Lilly USATaltz$21
1 payment
  • Meals for Taltz · 2024-10-15 · $21
Verrica PharmaceuticalsYcanth$21
1 payment
  • Meals for Ycanth · 2024-05-04 · $21

2023: $690

Payments by company in 2023
STRATA Skin SciencesXtrac$233
12 payments
  • Meals for Xtrac · 2023-12-19 · $21
  • Meals for Xtrac · 2023-12-06 · $25
  • Meals for Xtrac · 2023-10-30 · $19
  • Meals for Xtrac · 2023-10-19 · $26
  • Meals for Xtrac · 2023-10-12 · $18
  • Meals for Xtrac · 2023-10-12 · $19
  • Meals for Xtrac · 2023-10-10 · $19
  • Meals for Xtrac · 2023-09-18 · $16
  • Meals for Xtrac · 2023-08-29 · $22
  • Meals for Xtrac · 2023-08-21 · $24
  • Meals for Xtrac · 2023-04-03 · $17
  • Meals for Xtrac · 2023-02-28 · $9
AmgenOtezla$157
8 payments
  • Meals for Otezla · 2023-09-12 · $7
  • Meals for Otezla · 2023-07-18 · $25
  • Meals for Otezla · 2023-06-20 · $18
  • Meals for Otezla · 2023-06-06 · $32
  • Meals for Otezla · 2023-05-23 · $6
  • Meals for Otezla · 2023-05-16 · $18
  • Meals for Otezla · 2023-02-21 · $20
  • Meals for Otezla · 2023-01-24 · $31
IncyteOpzelura$144
13 payments
  • Meals for Opzelura · 2023-10-13 · $5
  • Meals for Opzelura · 2023-10-13 · $3
  • Meals for Iclusig · 2023-09-09 · $7
  • Meals for Iclusig · 2023-08-25 · $17
  • Meals for Opzelura · 2023-06-23 · $2
  • Meals for Opzelura · 2023-06-21 · $11
  • Meals for Opzelura · 2023-06-21 · $2
  • Meals for Opzelura · 2023-05-26 · $7
  • Meals for Opzelura · 2023-05-25 · $20
  • Meals for Opzelura · 2023-04-28 · $29
  • Meals for Opzelura · 2023-03-11 · $7
  • Meals for Opzelura · 2023-02-18 · $28
  • Meals for Opzelura · 2023-02-18 · $5
Novartis PharmaceuticalsCosentyx$111
4 payments
  • Meals for Cosentyx · 2023-04-21 · $14
  • Meals for Cosentyx · 2023-03-07 · $34
  • Meals for Cosentyx · 2023-02-07 · $30
  • Meals for Cosentyx · 2023-01-17 · $33
AbbVieSkyrizi$30
1 payment
  • Meals for Skyrizi · 2023-03-15 · $30
PfizerCibinqo$15
1 payment
  • Education for Cibinqo · 2023-04-12 · $15

2022: $384

Payments by company in 2022
AbbvieHumira$164
10 payments
  • Meals for Skyrizi · 2022-10-25 · $8
  • Meals for Skyrizi · 2022-10-14 · $33
  • Meals for Skyrizi · 2022-06-24 · $8
  • Meals for Humira · 2022-06-21 · $24
  • Meals for Humira · 2022-06-07 · $13
  • Meals for Humira · 2022-05-13 · $18
  • Meals for Rinvoq · 2022-04-29 · $14
  • Meals for Rinvoq · 2022-04-08 · $25
  • Meals for Humira · 2022-02-01 · $3
  • Meals for Humira · 2022-02-01 · $18
AmgenOtezla$138
5 payments
  • Meals for Otezla · 2022-11-29 · $17
  • Meals for Otezla · 2022-10-25 · $33
  • Meals for Otezla · 2022-09-13 · $25
  • Meals for Otezla · 2022-08-30 · $34
  • Meals for Otezla · 2022-08-16 · $28
Novartis PharmaceuticalsCosentyx$81
4 payments
  • Meals for Cosentyx · 2022-08-16 · $18
  • Meals for Cosentyx · 2022-07-26 · $18
  • Meals for Cosentyx · 2022-06-21 · $21
  • Meals for Cosentyx · 2022-03-08 · $24

2021: $342

Payments by company in 2021
AbbVieHumira$322
21 payments
  • Meals for Humira · 2021-12-07 · $5
  • Meals for Humira · 2021-12-03 · $20
  • Meals for Skyrizi · 2021-11-16 · $23
  • Meals for Skyrizi · 2021-10-22 · $14
  • Meals for Skyrizi · 2021-10-05 · $4
  • Meals for Humira · 2021-09-10 · $16
  • Meals for Humira · 2021-08-17 · $15
  • Meals for Humira · 2021-08-17 · $4
  • Meals for Humira · 2021-08-01 · $17
  • Meals for Humira · 2021-07-14 · $17
  • Meals for Humira · 2021-07-13 · $2
  • Meals for Humira · 2021-07-09 · $16
  • Meals for Skyrizi · 2021-06-11 · $17
  • Meals for Humira · 2021-06-08 · $24
  • Meals for Humira · 2021-05-28 · $21
  • Meals for Skyrizi · 2021-05-14 · $14
  • Meals for Skyrizi · 2021-04-30 · $23
  • Meals for Humira · 2021-04-16 · $20
  • Meals for Humira · 2021-04-02 · $16
  • Meals for Humira · 2021-03-05 · $16
  • Meals for Humira · 2021-01-08 · $20
IncyteOpzelura$19
1 payment
  • Meals for Opzelura · 2021-11-02 · $19

2020: $82

Payments by company in 2020
AbbVieSkyrizi$82
4 payments
  • Meals for Skyrizi · 2020-09-29 · $19
  • Meals for Humira · 2020-08-18 · $24
  • Meals for Humira · 2020-02-25 · $16
  • Meals for Skyrizi · 2020-01-13 · $23

2019: $70

Payments by company in 2019
AbbVieHumira$49
3 payments
  • Meals · 2019-11-26 · $16
  • Meals · 2019-10-08 · $15
  • Meals for Humira · 2019-08-20 · $18
Salix Pharmaceuticals a division of Bausch Health USXifaxan$21
1 payment
  • Meals for Xifaxan · 2019-06-24 · $21

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Eli Lilly and Company · An Open-Label 24-Week Study To Investigate the Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate-To-Severe Atopic Dermatitis and Skin of Color · 2023Their institution$3,411
Eli Lilly and Company · An Open-Label 24-Week Study To Investigate the Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate-To-Severe Atopic Dermatitis and Skin of Color · 2023This clinician$2

Checkups this office reported

4 measures · 2023

Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.

Medicare’s overall office score
88.2 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Checkup rates this office reported to Medicare
Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one100%That's most of the people this applied to.238
Medications listed in the chartVisits where the current medication list was documented100%That's most of the people this applied to.2,244
Melanoma: Continuity of Care - Recall SystemAs Medicare defines this measure100%30
Patients can see their records onlinePatients who were given electronic access to their health information99%That's most of the people this applied to.2,761

What the office says it does

Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.

  • Agreed to federal review of their records system
  • Did a security review of patient data
  • Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
  • Exempt from electronic case reporting
  • Exempt from immunization registry reporting
  • Exempt from query of the prescription drug monitoring program (pdmp)

Professional record

NPI
1316972201
Licence
CA A84286California A84286: Current · expires 2026-12-31
Group
Stanford Health Care · Direct Dermatology Professionals PC
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207N00000X (207N00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-07-11
NPI last updated
2023-10-12
NPI record certified
2023-10-12

This is when the NPI record was last certified, not a medical board exam.